Literature DB >> 26140632

Esophagogastric pathology in morbid obese patient: Preoperative diagnosis, influence in the selection of surgical technique.

Sergio Estévez-Fernández, Raquel Sánchez-Santos, Esther Mariño-Padín, Sonia González-Fernández, Juan Turnes-Vázquez.   

Abstract

INTRODUCTION: Given the difficulty in accessing to the excluded stomach after gastric bypass and the increase in gastroesophageal reflux after sleeve gastrectomy, it is justified to perform a preoperative fibrogastroscopy.The influence of the fibrogastroscopy (FGS) findings in the therapeutic approach is analyzed. PATIENTS AND METHODS: A retrospective study of preoperative FGS findings is performed, from 04/06 to 12/12. The influence of the FGS results on the surgical technique selection, in the endoscopic or medical treatment and its relation to gastric fistula is analyzed by means of multivariate regression (confounding factors: Age, body mass index, arterial hypertension, diabetes mellitus, antiplatelet therapy, surgical technique (bariatric surgery, sleeve gastrectomy).
RESULTS: Three hundred thirty one patients are included: 32.6% biopsy of gastric lesion; 27% gastritis; 18.1% hiatal hernia; 3% metaplasia; 0.6% Barrett esophagus; 2.1% esophagitis; 0.3% dysplasia; 0.3 Schatzky´s ring; 1.5% incompetent cardia; 2.4% duodenitis; 0.3% gastric erosions; 0.6% gastric xanthoma; 1.8%, gastric polyp; 1.6% duodenal ulcer; 0.6% papulo-erosive gastritis; 0.6% esophageal papilloma; 0.3% submucosal tumor. Helicobacter pylori+ 30.2% (triple therapy eradication in all patients). The FGS findings led to a variation in the surgical technique or to the completion of endoscopic treatment in 22.2% of cases.The gastric lesions did not influence the development of gastric fistula. Independent prognostic factors of fistula: Sleeve gastrectomy (7.9% vs. 2.7%; p = 0.02; OR: 1.38 IC95: 1.01-1.87) and the body mass index > 50 kg/m2) (6.7% vs. 2.2%; p = 0.04; OR: 3.7 IC95: 1.12-12.4).
CONCLUSIONS: The diagnosis of gastroesophageal disease through preoperative FGS motivated variations in the therapeutic approach in 52% of patients, so we consider essential to include the preoperative FGS in bariatric surgery.

Entities:  

Mesh:

Year:  2015        PMID: 26140632

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  5 in total

1.  The Role of Routine Upper Gastrointestinal Endoscopy Before Bariatric Surgery.

Authors:  Samuel R Fernandes; Liliane C Meireles; Luís Carrilho-Ribeiro; José Velosa
Journal:  Obes Surg       Date:  2016-09       Impact factor: 4.129

Review 2.  Is Routine Preoperative Esophagogastroduodenoscopy Screening Necessary Prior to Laparoscopic Sleeve Gastrectomy? Review of 1555 Cases and Comparison with Current Literature.

Authors:  Asaad Salama; Tamer Saafan; Walid El Ansari; Mohsen Karam; Moataz Bashah
Journal:  Obes Surg       Date:  2018-01       Impact factor: 4.129

3.  Barrett's Oesophagus and Bariatric/Metabolic Surgery-IFSO 2020 Position Statement.

Authors:  Oliver M Fisher; Daniel L Chan; Michael L Talbot; Almino Ramos; Ahmad Bashir; Miguel F Herrera; Jacques Himpens; Scott Shikora; Kelvin D Higa; Lilian Kow; Wendy A Brown
Journal:  Obes Surg       Date:  2021-01-18       Impact factor: 4.129

4.  Submucosal Tunnel Endoscopic Resection of Gastric Lesion Before Obesity Surgery: a Case Series.

Authors:  Gianfranco Donatelli; Fabrizio Cereatti; Jean-Loup Dumont; Nelson Trelles; Panagiotis Lainas; Carmelisa Dammaro; Hadrian Tranchart; Filippo Pacini; Roberto Arienzo; Jean-Marc Chevalier; David Danan; Jean-Marc Catheline; Ibrahim Dagher
Journal:  Obes Surg       Date:  2020-08-17       Impact factor: 4.129

5.  Esophagitis After Bariatric Surgery: Large Cross-sectional Assessment of an Endoscopic Database.

Authors:  Reem Matar; Daniel Maselli; Eric Vargas; Jaruvongvanich Veeravich; Fateh Bazerbachi; Azizullah Beran; Andrew C Storm; Todd Kellogg; Barham K Abu Dayyeh
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.